- Axsome Therapeutics reported third-quarter revenue of $259.7 million. No further details on net income, earnings per share, or guidance were provided in the initial release.
Axsome Therapeutics reported third-quarter revenue of $259.7 million. No further details on net income, earnings per share, or guidance were provided in the initial release.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.